Literature DB >> 21046986

Comparative evaluation of Bacopa monniera and Panax quniquefolium in experimental anxiety and depressive models in mice.

Manavi Chatterjee1, Pinki Verma, Gautam Palit.   

Abstract

The present study was undertaken to compare medicinal plants against mixed anxiety-depressive disorder (MAD) to evaluate their potency in combating MAD disorders. Previous studies from our lab have shown that Bacopa monniera (BM), and Panax quniquefolium (PQ) have significant adaptogenic properties. Hence, we have further confirmed their activity in stress related disorders like anxiety and depression in animal model, rodents and assessed their efficacy. In our experimental protocol, gross behaviour was observed through Digiscan animal activity monitor. Anxiety was studied through light dark test, elevated plus maze test and holeboard test. Depression experiments were conducted following tail suspension test and forced swim test. Further, rotarod test was also used to study any defects in motor in-coordination in mice. It was observed that BM at the dose of 80 mg/kg (po) and PQ at 100 mg/kg (po) were effective as an anti-anxiety as well anti-depressant activity and had no motor in-coordination in mice. Hence, these extracts can be used as a potent therapeutic agent in treating mixed anxiety-depressive disorder (MAD).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21046986

Source DB:  PubMed          Journal:  Indian J Exp Biol        ISSN: 0019-5189            Impact factor:   0.818


  14 in total

1.  Evaluation of the antipsychotic potential of Panax quinquefolium in ketamine induced experimental psychosis model in mice.

Authors:  Manavi Chatterjee; Seema Singh; Reena Kumari; Anil Kumar Verma; Gautam Palit
Journal:  Neurochem Res       Date:  2011-12-22       Impact factor: 3.996

2.  Effects of a high-fat diet and bamboo extract supplement on anxiety- and depression-like neurobehaviours in mice.

Authors:  Adeline Del Rosario; Mindy M McDermott; Jun Panee
Journal:  Br J Nutr       Date:  2012-02-07       Impact factor: 3.718

Review 3.  Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.

Authors:  Jerome Sarris; Erica McIntyre; David A Camfield
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

4.  Antidepressant activity of brahmi in albino mice.

Authors:  Sldv Ramana Murty Kadali; Das M C; Srinivasa Rao A S R; Karuna Sri G
Journal:  J Clin Diagn Res       Date:  2014-03-15

5.  Effects of Hypericum Scabrum extract on anxiety and oxidative stress biomarkers in rats fed a long-term high-fat diet.

Authors:  Ahmad Ganji; Iraj Salehi; Abdolrahman Sarihi; Siamak Shahidi; Alireza Komaki
Journal:  Metab Brain Dis       Date:  2016-12-15       Impact factor: 3.584

6.  Neuroprotective effects of Bacopa monnieri in experimental model of dementia.

Authors:  Neetu Saini; Devinder Singh; Rajat Sandhir
Journal:  Neurochem Res       Date:  2012-06-15       Impact factor: 3.996

7.  Alteration in 5-HT₂C, NMDA receptor and IP3 in cerebral cortex of epileptic rats: restorative role of Bacopa monnieri.

Authors:  Amee Krishnakumar; T R Anju; Pretty Mary Abraham; C S Paulose
Journal:  Neurochem Res       Date:  2014-12-13       Impact factor: 3.996

8.  Bacopa monnieri ameliorates memory deficits in olfactory bulbectomized mice: possible involvement of glutamatergic and cholinergic systems.

Authors:  Xoan Thi Le; Hang Thi Nguyet Pham; Phuong Thi Do; Hironori Fujiwara; Ken Tanaka; Feng Li; Tai Van Nguyen; Khoi Minh Nguyen; Kinzo Matsumoto
Journal:  Neurochem Res       Date:  2013-08-15       Impact factor: 3.996

9.  Anti-anxiety and anti-depressant activities of Sarasvata choorna in experimental animals.

Authors:  Kshama Gupta; B K Ashok; B Ravishankar; A B Thakar
Journal:  Ayu       Date:  2011-10

10.  A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system.

Authors:  Hee Jin Kim; Pitna Kim; Chan Young Shin
Journal:  J Ginseng Res       Date:  2013-03       Impact factor: 6.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.